A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

Gợi ý tài liệu liên quan:

• Differences between physician and patient preferences for cancer treatments: A systematic review

  13 trang 171 0 0

• Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer

  6 trang 166 0 0

• Immune checkpoint inhibitors and their impact on liver enzymes and attenuation

  7 trang 142 0 0

• 2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France

  9 trang 119 0 0

• Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment – oxaliplatin subscale: A prospective cohort study

  12 trang 93 0 0

• LAP3 contributes to IFN-γ-induced arginine depletion and malignant transformation of bovine mammary epithelial cells

  19 trang 74 0 0

• Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating selected features of TGFβ inhibition

  17 trang 64 0 0

• Determinants of late-stage cervical cancer presentation in Ethiopia: A systematic review and meta-analysis

  9 trang 43 0 0

• Anti-proliferative activity of RIHMSQi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases

  12 trang 38 0 0

• Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer

  17 trang 37 0 0

• Association of levels of metabolites with the safe margin of rectal cancer surgery: A metabolomics study

  13 trang 37 0 0

• The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

  11 trang 37 0 0

• Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia

  9 trang 35 0 0

• Tracking tumor alteration in glioma through serum fibroblast activation protein combined with image

  10 trang 35 0 0

• Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome

  11 trang 34 0 0

• Appropriate dose of regorafenib based on body weight of colorectal cancer patients: A retrospective cohort study

  9 trang 33 0 0

• First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFRmutated non-small cell Lung cancer with brain metastases: A systematic review and meta-analysis

  11 trang 32 0 0

• Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer

  16 trang 32 0 0

• Exploring the geospatial epidemiology of breast cancer in Iran: Identifying significant risk factors and spatial patterns for evidence-based prevention strategies

  22 trang 32 0 0

• CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: A case-control study

  14 trang 32 0 0